Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Chinese Journal of Clinical Rational Drug Use》 2017-06
Add to Favorite Get Latest Update

Clinical effect of flupentixol and melitracen tablets combined with valsartan in treating hypertension with anxiety disorders

YAO Wei-hua;TAN Yong-qiang;Community Health Service Center of Chongming County;  
Objective To discuss the clinical effect of flupentixol and melitracen tablets combined with valsartan in treating hypertension with anxiety disorders. Methods A total of 100 cases of hypertension with anxiety disorders patients were selected from 2014 to 2015 in Community Health Service Center of Chongming County,which were divided into control group and observation group,50 cases in each group. Control group was treated with valsartan,observation group was treated with flupentixol and melitracen tablets based on control group. The clinical effect,HAMA,HAMD scores before and after treatment and the incidence of adverse reactions were compared between the two groups. Results The clinical effect of observation group was better than control group( P 0. 05). Before treatment,no statistically significant differences of HAMA,HAMD scores was found between the two group( P 0. 05); after treatment,the observation group of HAMA,HAMD scores were lower than control group( P 0. 05). No obvious adverse reactions was happened between the two groups. Conclusion Flupentixol and melitracen tablets combined with valsartan have an obviously clinical effect in treating hypertension with anxiety disorders,it can effectively relieve anxiety and depression of patients,and with good safety.
【CateGory Index】: R544.1;R749.72
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved